• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

299.8000 USD 5.1200 1.74%

As of 17:10:00 ET on 12/24/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 293.0700 High - Low: 302.5600 - 293.0000 Primary Exchange: NASDAQ GM
Volume: 1,260,851 52-Week Range: 207.4800 - 319.1400 Beta vs XNBI: 1.0004

ETF Chart for IBB

No chart data available.
  • IBB:US 299.8000
  • 1D
  • 1M
  • 1Y
294.6800
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / RENE CASIS
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-12-24) 299.7600
Assets (M) (on 2014-12-24) 6,834.4790
Shares out (M) 22.80
Market Cap (M) 6,835.44
% Premium 0.01
Average 52-Week % Premium 0.0090
Fund Leveraged N

Dividends for IBB

Dividend Type Omitted
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.15%

Performance for IBB

1-Month -0.12% 1-Year +33.18%
3-Month +7.34% 3-Year +42.79%
Year To Date +32.26% 5-Year +29.90%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 12/23/2014
Name Position Value % of Total
Biogen Idec Inc 1,813,766 608,990,072 8.929%
Amgen Inc 3,376,005 531,788,308 7.797%
Celgene Corp 4,908,857 520,927,905 7.638%
Gilead Sciences Inc 5,562,988 497,609,277 7.296%
Regeneron Pharmaceuticals Inc 1,119,860 441,280,833 6.470%
Vertex Pharmaceuticals Inc 2,367,195 269,268,431 3.948%
Illumina Inc 1,461,891 268,256,999 3.933%
Alexion Pharmaceuticals Inc 1,433,563 256,421,414 3.760%
Mylan Inc/PA 4,491,452 254,126,354 3.726%
BioMarin Pharmaceutical Inc 1,769,653 154,473,010 2.265%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil